Epinephrine Market Size, Scope, and Share by 2031
Epinephrine Market: Strategic Insights
Epinephrine Market
-
CAGR (2023 - 2031)8.3% -
Market Size 2021
US$ 2.63 Billion -
Market Size 2031
US$ 5.85 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Number of Anaphylaxis Cases
FUTURE TRENDS
- Introduction of generic version of epinephrine
OPPORTUNITIES
- Growing Pipeline of Epinephrine
Key Players
- MYLAN N V
- Abbott
- ALK ABELLO
- Amneal Pharma
- Kaleo
- LINCOLN MEDICAL LTD BioProject
- Teva Pharmaceuticals Ltd
- Adamis Pharmaceuticals Corporation Novartis AG
- Emirade
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product Type
- Prefilled Syringes
- Auto-Injectors
- Ampoules
- Vials
Application
- Anaphylaxis
- Superficial Bleeding
- Respiratory Disorders
- Cardiac Arrest
Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies